Delivery Order SPE2DB22D1106-SPE2DB24FEVK6
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $49,153.84 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565680281 AVYCAZ 2.5 gram vials, with a period of performance through September 5, 2024. This order is placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical supplies to support...
- This federal contract award, with ID SPE2DB22D2206|SPE2DB25FFG49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,103.28 firm fixed-price delivery order is for the supply of AVYCAZ 2.5 gram vials, with a completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,825.41, is for the delivery of AVYCAZ 2.5 gram vials and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,493.61 firm fixed-price delivery order is for the supply of AVYCAZ 2.5 GRAM VIALS, with a performance period ending on May 20, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a significant vendor for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) to...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of AVYCAZ 2.5 gram vials. The contract has a potential value of $7,806.46 and a completion date of February 23, 2024. AmerisourceBergen Drug Corp serves as the prime contractor, providing pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVH23, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $8,456.52 firm fixed-price delivery order is for the supply of 4,567,944,616 vials of the antibiotic medication AVYCAZ 2.5 gram. The contract has an ultimate completion date of April 17, 2025 and was awarded on April 16, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $8,459.74 from the Defense Logistics Agency (DLA) Troop Support Medical for the provision of pharmaceutical products and medical supplies. The award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $25,718.84 for the supply of pharmaceutical and medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award, valued at $14,640.99, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. Under this IDC, Amerisourcebergen serves as the primary supplier of a comprehensive range of pharmaceutical...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is a Delivery Order valued at $14,442.75. The contract is for the provision of pharmaceutical products and medical supplies to the Department of Defense (DoD), specifically to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEVK6Delivery Order
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product AVYCAZ 2.5 gram vials to the Defense Logistics Agency (DLA), a defense agency. The $19,257.60 firm-fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. As a major supplier of pharmaceuticals and medical products to federal agencies, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 6/5/24 |